Rtw Investments as of June 30, 2015
Portfolio Holdings for Rtw Investments
Rtw Investments holds 35 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals (ALNY) | 14.3 | $49M | 411k | 119.87 | |
| BioCryst Pharmaceuticals (BCRX) | 9.8 | $34M | 2.3M | 14.93 | |
| Kite Pharma | 7.1 | $24M | 400k | 60.97 | |
| Achillion Pharmaceuticals | 6.5 | $22M | 2.5M | 8.86 | |
| Incyte Corporation (INCY) | 5.9 | $20M | 195k | 104.21 | |
| Fifth Third Bancorp cnv pfd dep1/25 | 5.6 | $19M | 781k | 24.51 | |
| Arrowhead Research | 5.3 | $18M | 2.6M | 7.15 | |
| Dicerna Pharmaceuticals | 5.2 | $18M | 1.3M | 13.95 | |
| Agenus | 5.2 | $18M | 2.1M | 8.63 | |
| Bluebird Bio | 5.1 | $18M | 105k | 168.37 | |
| Dyax | 4.3 | $15M | 559k | 26.50 | |
| Five Prime Therapeutics | 4.1 | $14M | 560k | 24.84 | |
| Celldex Therapeutics | 3.5 | $12M | 472k | 25.22 | |
| Targacept | 2.2 | $7.4M | 2.7M | 2.79 | |
| La Jolla Pharmaceuticl Com Par | 2.0 | $7.0M | 284k | 24.51 | |
| Bristol Myers Squibb (BMY) | 1.9 | $6.5M | 98k | 66.54 | |
| Bristol Myers Squibb Co 01/15/2016 CALL 60 Long Option Calls Call Option (Principal) | 1.8 | $6.1M | 7.5k | 815.07 | |
| Symmetry Surgical | 1.8 | $6.1M | 701k | 8.72 | |
| Corium Intl | 1.4 | $4.9M | 355k | 13.69 | |
| Newlink Genetics Corporation | 1.3 | $4.4M | 100k | 44.27 | |
| iShares Barclays 20+ Yr Treas.Bond (TLT) | 1.1 | $3.9M | 33k | 117.45 | |
| United States Oil Fund | 1.0 | $3.3M | 165k | 19.88 | |
| Presbia | 0.8 | $2.9M | 350k | 8.22 | |
| Invuity | 0.7 | $2.3M | 165k | 14.12 | |
| Lipocine | 0.5 | $1.8M | 209k | 8.58 | |
| Cytrx | 0.5 | $1.7M | 447k | 3.72 | |
| Repros Therapeutics | 0.5 | $1.6M | 229k | 7.15 | |
| Biopharmx | 0.3 | $949k | 371k | 2.56 | |
| Nivalis Therapeutics | 0.1 | $455k | 30k | 15.17 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $367k | 20k | 18.35 | |
| Meridian Bioscience Inc. VIVO 10/16/2015 CALL 20 Long Option Calls Call Option (Principal) | 0.1 | $260k | 3.8k | 69.22 | |
| Zogenix | 0.1 | $192k | 114k | 1.68 | |
| Valeant Pharmaceuticals Intl VRX 10/16/2015 CALL 260 Long Option Calls Call Option (Principal) | 0.0 | $78k | 150.00 | 520.00 | |
| Fortress Biotech | 0.0 | $40k | 12k | 3.36 | |
| Berkshire Hathaway (BRK.B) | 0.0 | $7.0k | 50.00 | 140.00 |
